13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 83 holding rows worth $201,092,000.
- Accession
- 0001389933-19-000002
- Filer
- CIK 1389933
- Filed
- 2019-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, 83 entries on the cover page, a total value of $201,092,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $201,092,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LOXO ONCOLOGY INC | 548862101 | COM | 181,675 | $25,447,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 13,680,554 | $14,789,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 104,306 | $9,991,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 318,729 | $9,753,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 312,119 | $8,933,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 64,900 | $6,258,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 58,300 | $5,601,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 143,764 | $5,242,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 141,770 | $5,118,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 92,691 | $4,997,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 77,242 | $4,839,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 272,474 | $4,300,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 34,000 | $4,073,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 396,013 | $4,059,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 715,538 | $3,957,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 55,008 | $3,928,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 41,609 | $3,817,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 464,415 | $3,748,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 93,942 | $3,659,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 463,228 | $3,493,000 | thousands by filing date | |
| LUMINEX CORP | 55027E102 | COMMON STOCK | 138,391 | $3,198,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469AA6 | NOTE | 4,000,000 | $3,064,000 | thousands by filing date | principal |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 80,000 | $2,958,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 808,000 | $2,901,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 27,000 | $2,678,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 332,511 | $2,617,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 42,800 | $2,556,000 | thousands by filing date | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 540,637 | $2,227,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 148,617 | $2,087,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 47,900 | $2,014,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 66,200 | $1,886,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 143,611 | $1,867,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 228,939 | $1,717,000 | thousands by filing date | |
| INSULET CORP | 45784PAG6 | NOTE 1.375% | 1,500,000 | $1,590,000 | thousands by filing date | principal |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 237,683 | $1,500,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 179,200 | $1,371,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 21,500 | $1,367,000 | thousands by filing date | |
| VBI VACCINES INC | 91822J103 | COM NEW | 850,000 | $1,360,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 105,656 | $1,326,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 37,900 | $1,290,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 457,664 | $1,268,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 118,500 | $1,267,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 31,210 | $1,214,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $1,213,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 185,826 | $1,174,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 82,254 | $1,174,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 50,573 | $1,144,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 630,182 | $1,002,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 78,305 | $994,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 246,900 | $946,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 155,000 | $905,000 | thousands by filing date | |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 359,190 | $894,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 472,859 | $846,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 6,600 | $744,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 15,000 | $646,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 1,272,927 | $613,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 44,338 | $561,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 212,766 | $500,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 70,000 | $431,000 | thousands by filing date | |
| VALERITAS HLDGS INC | 91914N202 | COM NEW | 1,325,000 | $431,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 50,000 | $415,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 20,225 | $399,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 72,279 | $358,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 170,000 | $340,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 20,500 | $338,000 | thousands by filing date | |
| DEXCOM INC | 252131AF4 | NOTE 0.750% 5/1 | 250,000 | $336,000 | thousands by filing date | principal |
| ARCTURUS THERAPEUTICS LTD | M1492T105 | SHS | 72,805 | $330,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 3,000 | $322,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 1,666,666 | $317,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 137,600 | $316,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 100,000 | $309,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 31,494 | $284,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 14,500 | $240,000 | thousands by filing date | |
| SOL GEL TECHNOLOGIES | M8694L103 | SHS | 35,000 | $211,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339AA3 | NOTE 2.500% 2/0 | 250,000 | $201,000 | thousands by filing date | principal |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 54,569 | $177,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 26,084 | $176,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 65,500 | $136,000 | thousands by filing date | |
| Bowater Inc | 09066L105 | COMMON STOCKS | 100,000 | $91,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 30,000 | $88,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 10,000 | $72,000 | thousands by filing date | |
| ORAMED PHARMACEUTICALS INC | 68403P203 | COM NEW | 16,000 | $48,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 27,500 | $45,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-19-000002 | this filing | 2019-02-14 | acceptance time not in the bulk data set |